Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells.
Firestone
R A
RA
Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492-7660.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D004337:Drug Carriers; D006801:Humans; D008077:Lipoproteins, LDL / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D014677:Pharmaceutical Vehicles
D000970:Antineoplastic Agents; D004337:Drug Carriers; D008077:Lipoproteins, LDL; D014677:Pharmaceutical Vehicles